دورية أكاديمية
[Experience with using cefoperazone in cancer patients after bone marrow transplantation].
| العنوان: | [Experience with using cefoperazone in cancer patients after bone marrow transplantation]. |
|---|---|
| عنوان ترانسليتريتد: | Opyt primeneniia tsefoperazona u onkologicheskikh bol'nykh posle transplantatsii kostnogo mozga. |
| المؤلفون: | Afanas'ev BV, Zubarevskaia LS, Shmidt AV, Zabelina TS |
| المصدر: | Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] [Antibiot Khimioter] 1992 Aug; Vol. 37 (8), pp. 14-5. |
| نوع المنشور: | English Abstract; Journal Article |
| اللغة: | Russian |
| بيانات الدورية: | Publisher: Izdatelstvo Meditsina Country of Publication: Russia (Federation) NLM ID: 8803688 Publication Model: Print Cited Medium: Print ISSN: 0235-2990 (Print) Linking ISSN: 02352990 NLM ISO Abbreviation: Antibiot Khimioter Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Moskva : Izdatelstvo Meditsina Original Publication: Moskva : Meditsina, c1988- |
| مواضيع طبية MeSH: | Anemia, Aplastic/*surgery , Antineoplastic Agents/*adverse effects , Bone Marrow Transplantation/*adverse effects , Cefoperazone/*administration & dosage , Hodgkin Disease/*drug therapy , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*drug therapy , Leukemia, Myeloid, Acute/*drug therapy , Pancytopenia/*surgery , Surgical Wound Infection/*prevention & control, Adolescent ; Adult ; Anemia, Aplastic/chemically induced ; Antineoplastic Agents/therapeutic use ; Child ; Child, Preschool ; Female ; Hodgkin Disease/blood ; Humans ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/blood ; Leukemia, Myeloid, Acute/blood ; Leukemia, Myeloid, Acute/pathology ; Male ; Middle Aged ; Pancytopenia/chemically induced ; Postoperative Care |
| مستخلص: | Cefoperazone is a semisynthetic cephalosporin of the 3rd generation (cefobid, Pfizer, USA). It was used in monotherapy of 12 oncological patients during ++post-cytostatic aplasia of the bone marrow and peripheral pancytopenia after bone marrow transplantation. The results were favourable in 67 per cent of the patients: the body temperature normalized and no signs of any infection were evident. In 25 per cent of the patients the monotherapy failed and it was necessary to combine cefoperazone with aminoglycosides. Therefore, cefoperazone proved to be an efficient antibacterial drug, whose use was possible in the monotherapy of oncological patients after transplantation of the bone marrow. |
| المشرفين على المادة: | 0 (Antineoplastic Agents) 7U75I1278D (Cefoperazone) |
| تواريخ الأحداث: | Date Created: 19920801 Date Completed: 19930107 Latest Revision: 20161020 |
| رمز التحديث: | 20240627 |
| PMID: | 1456815 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 0235-2990 |
|---|